Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Weil

Showing results (71-80 of 323) with videos related to

Pageof 33
Sort By:
Critical Care Medicine|May 1, 1975
Reduction in colloid osmotic pressure associated with fatal progression of cardiopulmonary failureM Morissette, M H Weil, H Shubin
Critical Care Medicine|August 31, 2000
Research on postresuscitation myocardial dysfunction: potential limitations of isolated perfused heart modelsK Klouche, W Tang, M H Weil
Critical Care Medicine|August 31, 2000
Sublingual PCO2W Tang, J Bisera, M H Weil
Chest|July 23, 1998
Tissue hypercarbic acidosis as a marker of acute circulatory failure (shock)Y Sato, M H Weil, W Tang
JAMA|July 30, 1973
Recognition and management of pericardial tamponadeL Stein, H Shubin, M H Weil
Critical Care Medicine|December 1, 2000
Low-energy biphasic waveform defibrillation reduces the severity of postresuscitation myocardial dysfunctionW Tang, M H Weil, S Sun
Chest|May 1, 1974
Factors determining survival in patients with cardiac arrestJ Castagna, M H Weil, H Shubin
International Surgery|November 1, 1974
Corticosteroid therapy in circulatory shockM H Weil, H Shubin, H Nishijima
Heart & Lung : the Journal of Critical Care|January 1, 1973
Care of the critically ill patientM H Weil, H Shubin, A Soffer
JAMA|March 24, 1975
Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agentsM H Weil, H Shubin, R Carlson
Pageof 33

Showing results (71-80 of 323) with videos related to

Sort By:
Pageof 33
Critical Care Medicine|May 1, 1975
Reduction in colloid osmotic pressure associated with fatal progression of cardiopulmonary failureM Morissette, M H Weil, H Shubin
Critical Care Medicine|August 31, 2000
Research on postresuscitation myocardial dysfunction: potential limitations of isolated perfused heart modelsK Klouche, W Tang, M H Weil
Critical Care Medicine|August 31, 2000
Sublingual PCO2W Tang, J Bisera, M H Weil
Chest|July 23, 1998
Tissue hypercarbic acidosis as a marker of acute circulatory failure (shock)Y Sato, M H Weil, W Tang
JAMA|July 30, 1973
Recognition and management of pericardial tamponadeL Stein, H Shubin, M H Weil
Critical Care Medicine|December 1, 2000
Low-energy biphasic waveform defibrillation reduces the severity of postresuscitation myocardial dysfunctionW Tang, M H Weil, S Sun
Chest|May 1, 1974
Factors determining survival in patients with cardiac arrestJ Castagna, M H Weil, H Shubin
International Surgery|November 1, 1974
Corticosteroid therapy in circulatory shockM H Weil, H Shubin, H Nishijima
Heart & Lung : the Journal of Critical Care|January 1, 1973
Care of the critically ill patientM H Weil, H Shubin, A Soffer
JAMA|March 24, 1975
Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agentsM H Weil, H Shubin, R Carlson
Pageof 33